For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Genelux Corporation

USPTO Granted Patents = 30

% Expired Patents = 40.0

CIPO Patents = 1

EPO Patents = 10

Forward Citations = 1,170

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Aladar A Szalay (29 out of 44 patents)

Yong A Yu (25 out of 25 patents)

Qian Zhang (19 out of 58 patents)

4. Tatyana Timiryasova (13 out of 13 patents)

5. Nanhai G Chen (10 out of 15 patents)

6. Alexa Frentzen (4 out of 4 patents)

7. Shahrokh Shabahang (4 out of 5 patents)

8. Jochen Harald Stritzker (4 out of 4 patents)

9. Joseph Cappello (2 out of 26 patents)

10. Phil Hill (2 out of 2 patents)

11. Boris Minev (1 out of 10 patents)

12. Richard J Aguilar (1 out of 1 patent)

13. Jochen Stritzker (1 out of 3 patents)

14. Michael Hess (1 out of 1 patent)

15. Yuman Fong (4 patents)

30 patents: Sort by Forward Citations

1. 12338464 - Clonal strains of attenuated vaccinia viruses and methods of use thereof (2025-06-24),

2. 11149254 - Clonal strains of attenuated vaccinia viruses and methods of use thereof (2021-10-19),

3. 10851350 - Bioreactor production of virus from adherent cells (2020-12-01),

4. 10584317 - Modified vaccinia virus strains for use in diagnostic and therapeutic methods (2020-03-10),

5. 10463730 - Microorganisms for therapy (2019-11-05),

6. 10238700 - Oncolytic virus adjunct therapy with agents that increase virus infectivity (2019-03-26),

7. 9944903 - Modified vaccinia virus strains for use in diagnostic and therapeutic methods (2018-04-17),

8. 9492534 - Microorganisms for therapy (2016-11-15),

9. 9005602 - Modified vaccinia virus strains for use in diagnostic and therapeutic methods (2015-04-14),

10. 8865153 - Microorganisms for imaging and/or treatment of tumors (2014-10-21),

11. 8859256 - Method for detecting replication or colonization of a biological therapeutic (2014-10-14),

12. 8852927 - Microorganisms for imaging and/or treatment of tumors (2014-10-07),

13. 8784836 - Microorganisms for therapy (2014-07-22),

14. 8642257 - Vaccinia virus for diagnosis and therapy of tumors (2014-02-04),

15. 8586022 - Light emitting microorganisms and cells for diagnosis and therapy of tumors (2013-11-19),

Genelux Corporation is a biopharmaceutical company that specializes in the development of oncolytic viral immunotherapies for the treatment of cancer. With a focus on innovative genetic engineering approaches, Genelux aims to create advanced virus-based therapies that selectively target and kill cancer cells while sparing healthy tissues. Through extensive research and collaboration, the company is striving to revolutionize cancer treatment and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Genelux Corporation

30 Patents

#208 in San Diego, CA

#2,672 in California

#11,241 in US

#21,816 in the World

San Diego, CA, United States of America

Genelux Corporation

Forward Citations = 1,170

14 inventors:

Aladar A Szalay (29 out of 44 patents)

Yong A Yu (25 out of 25 patents)

Qian Zhang (19 out of 58 patents)

4. Tatyana Timiryasova (13 out of 13 patents)

5. Nanhai G Chen (10 out of 15 patents)

Please report any incorrect information to [email protected]

Loading…